World Health Organization Regional Office for the Western Pacific

Malaria

Malaria is still endemic in 10 countries of the Western Pacific Region, associated with poverty and retarding progress towards economic well-being among the affected communities.

In the past decade, national health authorities in several of these endemic countries have made considerable progress in reducing malaria morbidity and mortality.

Resistance to chloroquine and other commonly available antimalarial drugs is a major issue in malaria control in the Region, as it is worldwide. The problem is most critical in the countries of the Mekong region, where it is aggravated by the increasing proliferation of low-quality and counterfeit drugs, and widespread irrational drug use in the private sector.

[more on this health topic]

Fact sheets

News and press releases

23 January 2012
Good news on the malaria front
[full text]

[more news]

Relevant publications and documents

Malaria microscopy quality assurance manual - Version 1
Early diagnosis and prompt, effective treatment is the basis for the management of malaria and key to reducing malaria mortality and morbidity. An acceptable microscopy service is one that is cost-effective, provides results that are consistently accurate and timely enough to have a direct impact on treatment. This requires a comprehensive and active quality assurance (QA) programme. This manual outlines a hierarchical structure based on retraining, validation and the development of competency standards designed to ensure the quality of diagnosis necessary for a successful malaria programme, while remaining within the financial and personnel resources likely to be available. The mode of implementation of the QA system outlined in this manual will vary according to the organization of the national laboratory services dealing with malaria, which may fall under the national malaria control programme, or under a separate laboratory structure working closely with the malaria programme.  

Review of the Malaria Drug Efficacy Situation in 10 Countries of the WHO Western Pacific Region, 1987-2003
In order to address the need for a continuous evaluation of the efficacy of antimalarial drugs, the WHO Regional Office for the Western Pacific conducted a systematic inventory of in vivo and in vitro drug efficacy studies from the past 15 years. The studies were gathered from our countries in the Mekong region (Cambodia, China, the Lao People's Democratic Republic and Viet Nam), Malaysia, the Philippines and the Republic of Korea, as well as from the Pacific island countries of Papua New Guinea, Solomon Islands and Vanuatu, which are endemic for malaria. A database was created to facilitate analysis and tracking of drug efficacy. The main objectives of the initiative were:

[more publications and documents]

Upcoming meetings and events

No meeting/event planned at this time.



Print      Bookmark   Feedback   More